Idexx Laboratories (IDXX) Operating Expenses (2009 - 2026)

Idexx Laboratories' Operating Expenses history runs 18 years deep, the most recent figure standing at $360.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 17.37% year-over-year to $360.2 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 7.09% YoY), while the FY2025 annual figure was $1.3 billion, up 3.91% from the prior year.
• Operating Expenses for Q1 2026 stood at $360.2 million, up from $342.5 million in the prior quarter.
• The five-year high for Operating Expenses was $360.2 million in Q1 2026, with the low at $126.5 million in Q4 2022.
• The 5-year median for Operating Expenses is $292.1 million (2024), against an average of $263.5 million.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses sank 72.17% in 2022, then soared 113.24% in 2024.
• Idexx Laboratories' Operating Expenses stood at $126.5 million in 2022, then jumped by 81.12% to $229.1 million in 2023, then jumped by 34.89% to $309.0 million in 2024, then increased by 10.85% to $342.5 million in 2025, then rose by 5.15% to $360.2 million in 2026.
• Business Quant data shows IDXX's Operating Expenses at $360.2 million in Q1 2026, $342.5 million in Q4 2025, and $328.5 million in Q3 2025.